| 000 | 01495 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513171536.0 | ||
| 264 | 0 | _c19990719 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0145-5680 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerbeek, M M | |
| 245 | 0 | 0 |
_aHuman brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bCellular and molecular biology (Noisy-le-Grand, France) _cFeb 1999 |
||
| 300 |
_a37-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xetiology |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xmetabolism |
| 650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xmetabolism |
| 650 | 0 | 4 |
_aAmyloidosis _xetiology |
| 650 | 0 | 4 |
_aApolipoproteins _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xetiology |
| 650 | 0 | 4 |
_aChymotrypsin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHeparan Sulfate Proteoglycans _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aPericytes _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aOtte-Höller, I | |
| 700 | 1 | _aRuiter, D J | |
| 700 | 1 | _ade Waal, R M | |
| 773 | 0 |
_tCellular and molecular biology (Noisy-le-Grand, France) _gvol. 45 _gno. 1 _gp. 37-46 |
|
| 999 |
_c10059466 _d10059466 |
||